Charles D. Snow

FDA Moves Beyond COVID-19, But Impacts on COVID-19 Era Clinical Trials RemainOctober 12th, 2023
On September 18, 2023, FDA published an updated, final iteration of guidance for immediate implementation entitled, “Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies.” This final guidance replaces and supersedes the March 2020 …
Swift Enforcement Against COVID FraudstersMay 1st, 2020
Since HHS declared a public health emergency caused by COVID-19 in February 2020, there has been an overwhelming response to develop and market products to treat or mitigate the effects of the virus. Unfortunately, bad apples still are out there preying upon consumer fears and …